FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2026
Back to search
Official data from USPTO
GLUCOMYRAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLUCOMYRAL
ST13
US500000079420351Class
1, 5
Filing
79420351
Registration
8112917
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/05/2026
Trademark type
Word
Nice classes
1, 5
Filing date
02/27/2025
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
08/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
IT
Examiner
MCCAULEY, BRENDAN D
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NUTRA FUTURA S.R.L.
Representatives
Theodore R. Remaklus Thompson Hine LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in the pharmaceutical industry; chemical preparations for use in the food industry; chemicals for use as ingredients during production in the pharmaceuticalfoodsupplement industries; active chemical ingredients for use in the manufacture in the pharmaceuticalfoodsupplement industries; chemicals for industrial use in the production of dietary supplementsnutritional supplementsnutraceutical supplementsfood supplementsvitamin supplementssupplements containing microorganisms; chemicals for industrial use in the production of pharmaceuticalsmedical and veterinary preparationsfood and dietary substances for medical or veterinary usefood supplements for humans and animals; plant extractsother than essential oilsfor industrial use in the production of pharmaceuticals and food supplements; plant extractsother than essential oilsfor industrial purposes; botanical extractsother than essential oilsfor industrial use used in the manufacture of pharmaceuticalsmedical and veterinary preparationsfoods and dietary substances for medical or veterinary usefood supplements for humans and animals; plant extractsother than essential oilsfor the food industry; herbal extractsother than for essential oilsfor the production of pharmaceuticals; preparations of microorganisms not for medical or veterinary use; bacteriological preparations not for medical or veterinary use; cultures of microorganisms for industrial purposes; cultures of microorganisms for the food and supplement industry; bacteriological preparations for the food and supplement industry; milk ferments for the food and supplement industry
Class 5
Pharmaceuticalsmedical and veterinary preparationspharmaceutical preparations for woundsfor treating allergiestreating hypertensionfor skin caremedical preparationsbath preparations for medical purposesmineral preparations for medical purposesglucose preparations for medical purposesveterinary preparationsenzyme preparations for veterinary purposesbacteriological preparations for veterinary purposesdiagnostic preparations for veterinary purposes; dietetic food and substances adapted for medical or veterinary usefood for babies; food supplements for humans and animals; food supplements and dietetic preparations adapted for medical purposes; nutritional supplements for medical use; dietary foods for medical usedietetic foods adapted for medical use; dietetic beverages for medical use; food supplements for humansnot for medical use; vitamin supplements; nutritional supplements; protein food supplements; vitamin and mineral supplements; probiotic supplements; food supplementsantioxidant supplements; anti-inflammatory preparations; mineral food supplements; nutraceutical preparations for therapeutic or medical usenutraceuticals for the treatment of high cholesterol and nutraceuticals for use as a dietary supplement for promoting digestion; nutraceuticals for use as dietary supplements; phytotherapy preparations for medical use; herbal extractsother than essential oilsfor medical use; extractsother than essential oilsof medicinal plants and herbs; plant extractsother than essential oilsfor pharmaceutical use; dietary fibredietary fibre for treating constipationdietary fibre to aid digestiondietary fiber for use as an ingredient in the manufacture of dietary supplements; vitamins; nutritional supplements not for therapeutic use; milk ferments for pharmaceutical use; cultures of microorganisms for dietary supplements; cultures of microorganisms for medical and veterinary use; anti-microbial preparationsanti-microbial hand-sanitizing preparationsanti-microbial preparations for preventing moldmildewbacteriaantimicrobial preparations for inhibiting microbiological decomposition in foodbeveragesanimal feedpharmaceuticals; bacterial preparations for medical or veterinary use; biological preparations for medical and veterinary usebiological preparations for the treatment of cancerbiological preparations for the prevention and treatment of cancerinfectious diseases and viral infectionsbiologics in the nature of pharmaceutical preparations for the treatment of cancer; preparations of microorganisms for medical or veterinary use; medical preparations for personal hygiene or for sanitary usedisinfectants for hygiene purposessterilizing preparationschemical preparations for sanitary purposessanitary preparations for medical use
Publications
History of USPTO decisions and trademark events.
29 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/27/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2025
RFNT
REFUSAL PROCESSED BY IB
10/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/13/2025
RFRR
REFUSAL PROCESSED BY MPU
09/13/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/05/2025
CNRT
NON-FINAL ACTION WRITTEN
08/04/2025
DOCK
ASSIGNED TO EXAMINER
07/31/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/18/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/31/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
03/27/2025
Continuous trademark protection
Get notified about every new filing that threatens GLUCOMYRAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.